{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:14:52Z","timestamp":1785428092053,"version":"3.56.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-202","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T03:04:11Z","timestamp":1401764651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Sally-Ann","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Caslake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hassiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jahoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"McConnachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,3]]},"reference":[{"key":"2097_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/gps.930100106","volume":"10","author":"VP Prasher","year":"1995","unstructured":"Prasher VP: Age-specific prevalence, thyroid dysfunction and depressive symptomatology in adults with Down syndrome and dementia. Int J Geriatr Psychiatry. 1995, 10: 25-31. 10.1002\/gps.930100106.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2097_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1365-2788.2000.00263.x","volume":"44","author":"AJ Holland","year":"2000","unstructured":"Holland AJ, Hon J, Huppert FA, Stevens F: Incidence and course of dementia in people with Down\u2019s syndrome: findings from a population-based study. J Intellect Disabil Res. 2000, 44: 138-146.","journal-title":"J Intellect Disabil Res"},{"key":"2097_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","volume":"43","author":"DMA Mann","year":"1988","unstructured":"Mann DMA: The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev. 1988, 43: 99-136. 10.1016\/0047-6374(88)90041-3.","journal-title":"Mech Ageing Dev"},{"key":"2097_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","volume":"25","author":"A Mudher","year":"2002","unstructured":"Mudher A, Lovestone S: Alzheimer\u2019s disease\u2013Do tauists and Baptists finally shake hands?. Trends Neurosci. 2002, 25: 22-26. 10.1016\/S0166-2236(00)02031-2.","journal-title":"Trends Neurosci"},{"key":"2097_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowdon","year":"1997","unstructured":"Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA. 1997, 277: 813-817. 10.1001\/jama.1997.03540340047031.","journal-title":"JAMA"},{"key":"2097_CR6","doi-asserted-by":"publisher","first-page":"c4670","DOI":"10.1136\/bmj.c4670","volume":"341","author":"M Richards","year":"2010","unstructured":"Richards M, Brayne C: What do we mean by Alzheimer\u2019s disease?. BMJ. 2010, 341: c4670-10.1136\/bmj.c4670.","journal-title":"BMJ"},{"key":"2097_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0021-9150(89)90110-X","volume":"76","author":"S Yl\u00e4-Herttuala","year":"1989","unstructured":"Yl\u00e4-Herttuala S, Luoma J, Nikkari T, Kivim\u00e4ki T: Down\u2019s syndrome and atherosclerosis. Atherosclerosis. 1989, 76: 269-272. 10.1016\/0021-9150(89)90110-X.","journal-title":"Atherosclerosis"},{"key":"2097_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/bmj.2.6081.226","volume":"2","author":"JC Murdoch","year":"1977","unstructured":"Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG: Down\u2019s syndrome: an atheroma-free model?. Br Med J. 1977, 2: 226-228. 10.1136\/bmj.2.6081.226.","journal-title":"Br Med J"},{"key":"2097_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neulet.2007.02.023","volume":"416","author":"WB Zigman","year":"2007","unstructured":"Zigman WB, Schupf N, Jenkins EC, Urv TK, Tycko B, Silverman W: Cholesterol level, statin use and Alzheimer\u2019s disease in adults with Down syndrome. Neurosci Lett. 2007, 416: 279-284. 10.1016\/j.neulet.2007.02.023.","journal-title":"Neurosci Lett"},{"key":"2097_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.tins.2006.09.002","volume":"29","author":"OM Andersen","year":"2006","unstructured":"Andersen OM, Willnow TE: Lipoprotein receptors in Alzheimer\u2019s disease. Trends Neurosci. 2006, 29: 687-694. 10.1016\/j.tins.2006.09.002.","journal-title":"Trends Neurosci"},{"key":"2097_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/418932a","volume":"418","author":"IJ Deary","year":"2002","unstructured":"Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ: Cognitive change and the APOE \u03f54 allele. Nature. 2002, 418: 932-10.1038\/418932a. A published erratum appears in Nature 2002, 419:450","journal-title":"Nature"},{"key":"2097_CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcn\/87.2.449","volume":"87","author":"LJ Whalley","year":"2008","unstructured":"Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC: n-3 fatty acid erythrocyte membrane content, APOE \u03f54, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr. 2008, 87: 449-454.","journal-title":"Am J Clin Nutr"},{"key":"2097_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0892-0362(95)91641-W","volume":"17","author":"OV Pavlov","year":"1995","unstructured":"Pavlov OV, Bobryshev YV, Balabanov YV, Ashwell K: An in vitro study of the effects of lovastatin on human fetal brain cells. Neurotoxicol Teratol. 1995, 17: 31-39. 10.1016\/0892-0362(95)91641-W.","journal-title":"Neurotoxicol Teratol"},{"key":"2097_CR14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.neurobiolaging.2005.09.011","volume":"27","author":"D Cao","year":"2006","unstructured":"Cao D, Fukuchi K, Wan H, Kim H, Li L: Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging. 2006, 27: 1632-1643. 10.1016\/j.neurobiolaging.2005.09.011.","journal-title":"Neurobiol Aging"},{"key":"2097_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/0269881107081553","volume":"22","author":"B Sharma","year":"2008","unstructured":"Sharma B, Singh N, Singh M: Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer\u2019s disease by pitavastatin and donepezil. J Psychopharmacol. 2008, 22: 162-171. 10.1177\/0269881107081553.","journal-title":"J Psychopharmacol"},{"key":"2097_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1212\/WNL.57.6.985","volume":"57","author":"V Chandra","year":"2001","unstructured":"Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, Ganguli M: Incidence of Alzheimer\u2019s disease in a rural community in India: the Indo-US study. Neurology. 2001, 57: 985-989. 10.1212\/WNL.57.6.985.","journal-title":"Neurology"},{"issue":"3 Suppl 2","key":"2097_CR17","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/00002093-200607001-00005","volume":"20","author":"HC Hendrie","year":"2006","unstructured":"Hendrie HC, Murrell J, Gao S, Unverzagt FW, Ogunniyi A, Hall KS: International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis Assoc Disord. 2006, 20 (3 Suppl 2): S42-S46.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2097_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","volume":"137","author":"M Kivipelto","year":"2002","unstructured":"Kivipelto M, Helkala EL, Laasko MP, H\u00e4nninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H: Apolipoprotein E \u03f54 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002, 137: 149-155. 10.7326\/0003-4819-137-3-200208060-00006.","journal-title":"Ann Intern Med"},{"key":"2097_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","volume":"45","author":"GP Jarvik","year":"1995","unstructured":"Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB: Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer\u2019s disease: a case\u2013control study. Neurology. 1995, 45: 1092-1096. 10.1212\/WNL.45.6.1092.","journal-title":"Neurology"},{"key":"2097_CR20","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA: Statins and the risk of dementia. Lancet. 2000, 356: 1627-1631. 10.1016\/S0140-6736(00)03155-X. A published erratum appears in Lancet 2001, 357:562","journal-title":"Lancet"},{"key":"2097_CR21","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000, 57: 1439-1443. 10.1001\/archneur.57.10.1439.","journal-title":"Arch Neurol"},{"key":"2097_CR22","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1046\/j.1532-5415.2002.50515.x","volume":"50","author":"EG Rodriguez","year":"2002","unstructured":"Rodriguez EG, Dodge HH, Birzescu MA, Stoehr GP, Ganguli M: Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study. J Am Geriatr Soc. 2002, 50: 1852-1856. 10.1046\/j.1532-5415.2002.50515.x.","journal-title":"J Am Geriatr Soc"},{"key":"2097_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.59.3.378","volume":"59","author":"K Yaffe","year":"2002","unstructured":"Yaffe K, Barrett-Connor E, Lin F, Grady D: Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002, 59: 378-384. 10.1001\/archneur.59.3.378.","journal-title":"Arch Neurol"},{"key":"2097_CR24","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/01.WNL.0000160114.42643.31","volume":"64","author":"C Dufouil","year":"2005","unstructured":"Dufouil C, Richard F, Fi\u00e9vet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alp\u00e9rovitch A: APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology. 2005, 64: 1531-1538. 10.1212\/01.WNL.0000160114.42643.31.","journal-title":"Neurology"},{"key":"2097_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","volume":"62","author":"PP Zandi","year":"2005","unstructured":"Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC, Cache County Study Investigators: Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005, 62: 217-224. 10.1001\/archpsyc.62.2.217.","journal-title":"Arch Gen Psychiatry"},{"key":"2097_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000111583","volume":"29","author":"K Rockwood","year":"2007","unstructured":"Rockwood K, Howlett S, Fisk J, Darvesh S, Tuokko H, Hogan DB, Wolfson C, McDowell I: Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status. Neuroepidemiology. 2007, 29: 201-207. 10.1159\/000111583.","journal-title":"Neuroepidemiology"},{"key":"2097_CR27","first-page":"CD003160","volume":"2","author":"B McGuinness","year":"2009","unstructured":"McGuinness B, Craig D, Bullock R, Passmore P: Statins for the prevention of dementia. Cochrane Database Syst Rev. 2009, 2: CD003160-","journal-title":"Cochrane Database Syst Rev"},{"key":"2097_CR28","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/01.wnl.0000182897.18229.ec","volume":"65","author":"C Bernick","year":"2005","unstructured":"Bernick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, Kuller L, Cardiovascular Health Study Collaborative Research Group: Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology. 2005, 65: 1388-1394. 10.1212\/01.wnl.0000182897.18229.ec.","journal-title":"Neurology"},{"key":"2097_CR29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","volume":"62","author":"TD Rea","year":"2005","unstructured":"Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH: Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005, 62: 1047-1051. 10.1001\/archneur.62.7.1047.","journal-title":"Arch Neurol"},{"key":"2097_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","volume":"71","author":"C Cramer","year":"2008","unstructured":"Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD: Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology. 2008, 71: 344-350. 10.1212\/01.wnl.0000319647.15752.7b.","journal-title":"Neurology"},{"key":"2097_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","volume":"80","author":"MDM Haag","year":"2009","unstructured":"Haag MDM, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM: Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2009, 80: 13-17. 10.1136\/jnnp.2008.150433.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2097_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1532-5415.2010.02906.x","volume":"58","author":"G Li","year":"2010","unstructured":"Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JC, Larson EB: Age-varying association between statin use and incident Alzheimer\u2019s disease. J Am Geriatr Soc. 2010, 58: 1311-1317. 10.1111\/j.1532-5415.2010.02906.x.","journal-title":"J Am Geriatr Soc"},{"key":"2097_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/jech.2009.100826","volume":"65","author":"MA Beydoun","year":"2011","unstructured":"Beydoun MA, Beason-Held LL, Kitner-Triolo MH, Beydoun HA, Ferrucci L, Resnick SM, Zonderman AB: Statins and serum cholesterol\u2019s associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health. 2011, 65: 949-957. 10.1136\/jech.2009.100826.","journal-title":"J Epidemiol Community Health"},{"key":"2097_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/WAD.0b013e318180f55b","volume":"23","author":"HT Horsdal","year":"2009","unstructured":"Horsdal HT, Olesen AV, Gasse C, S\u00f8rensen HT, Green RC, Johnsen SP: Use of statins and risk of hospitalization with dementia: a Danish population-based case\u2013control study. Alzheimer Dis Assoc Disord. 2009, 23: 18-22. 10.1097\/WAD.0b013e318180f55b.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2097_CR35","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1212\/01.WNL.0000142963.90204.58","volume":"63","author":"G Li","year":"2004","unstructured":"Li G, Higdon R, Kukull WA, Peskind E, Van Valen Moore K, Tsuang D, van Belle G, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB: Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology. 2004, 63: 1624-1628. 10.1212\/01.WNL.0000142963.90204.58.","journal-title":"Neurology"},{"key":"2097_CR36","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","volume":"70","author":"Z Arvanitakis","year":"2008","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA, Bennett DA: Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008, 70: 1795-1802.","journal-title":"Neurology"},{"key":"2097_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/gps.1093","volume":"19","author":"JM Starr","year":"2004","unstructured":"Starr JM, McGurn B, Whiteman M, Pattie A, Whalley LJ, Deary IJ: Life long changes in cognitive ability are associated with prescribed medications in old age. Int J Geriatr Psychiatry. 2004, 19: 327-332. 10.1002\/gps.1093.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2097_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/archneur.64.7.1007","volume":"64","author":"N Schupf","year":"2007","unstructured":"Schupf N, Patel B, Pang D, Zigman WB, Silverman W, Mehta PD, Mayeux R: Elevated plasma \u03b2-amyloid peptide A\u03b242 levels, incident dementia, and mortality in Down syndrome. Arch Neurol. 2007, 64: 1007-1013. 10.1001\/archneur.64.7.1007.","journal-title":"Arch Neurol"},{"key":"2097_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group: MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002, 360: 7-22.","journal-title":"Lancet"},{"key":"2097_CR40","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1111\/j.1532-5415.2007.01415.x","volume":"55","author":"CJ Packard","year":"2007","unstructured":"Packard CJ, Westendorp RGJ, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C, Prospective Study of Pravastatin in the Elderly at Risk Group: Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc. 2007, 55: 1777-1785. 10.1111\/j.1532-5415.2007.01415.x.","journal-title":"J Am Geriatr Soc"},{"key":"2097_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2008-13209","volume":"13","author":"CM Carlsson","year":"2008","unstructured":"Carlsson CM, Gleason CE, Hess TM, Moreland KA, Blazel HM, Koscik RL, Schreiber NT, Johnson SC, Atwood CS, Puglielli L, Hermann BP, McBride PE, Stein JH, Sager MA, Asthana S: Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer\u2019s disease. J Alzheimers Dis. 2008, 13: 187-197.","journal-title":"J Alzheimers Dis"},{"key":"2097_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00228-005-0073-z","volume":"62","author":"GP Paarole","year":"2006","unstructured":"Paarole GP, Baheti NN, Kulkarni PM, Panchal NV: Effects of atorvastatin on higher functions. Eur J Clin Pharmacol. 2006, 62: 259-265. 10.1007\/s00228-005-0073-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4 Suppl","key":"2097_CR43","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/j.jalz.2010.05.470","volume":"6","author":"CM Carlsson","year":"2010","unstructured":"Carlsson CM, Gleason CE, Johnson SC, Xu G, Huang Y, Barnet J, Fain S, Blazel H, Zetterberg H, Blennow K, Hermann BP, Dowling NM, Newman GC, Puglielli L, Atwood CS, Rowley H, Sager M, Asthana S: A randomized, double-blind placebo-controlled trial of simvastatin on CSF, MRI, and cognitive biomarkers in middle-aged adults at risk for Alzheimer\u2019s disease: The ESPRIT Study [Abstract]. Alzheimers Dement. 2010, 6 (4 Suppl): S151-S152.","journal-title":"Alzheimers Dement"},{"key":"2097_CR44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archneur.62.5.753","volume":"62","author":"DL Sparks","year":"2005","unstructured":"Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C: Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005, 62: 753-757. 10.1001\/archneur.62.5.753.","journal-title":"Arch Neurol"},{"key":"2097_CR45","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","volume":"74","author":"HH Feldman","year":"2010","unstructured":"Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A, LEADe Investigators: Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 2010, 74: 956-964. 10.1212\/WNL.0b013e3181d6476a.","journal-title":"Neurology"},{"key":"2097_CR46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1017\/S1092852900019817","volume":"10","author":"GL Xiong","year":"2005","unstructured":"Xiong GL, Benson A, Doraiswamy PM: Statins and cognition: What can we learn from existing randomized trials?. CNS Spectr. 2005, 10: 867-874.","journal-title":"CNS Spectr"},{"key":"2097_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11883-007-0012-9","volume":"9","author":"LH Kuller","year":"2007","unstructured":"Kuller LH: Statins and dementia. Curr Atheroscler Rep. 2007, 9: 154-161. 10.1007\/s11883-007-0012-9.","journal-title":"Curr Atheroscler Rep"},{"key":"2097_CR48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.7326\/0003-4819-159-10-201311190-00007","volume":"159","author":"K Richardson","year":"2013","unstructured":"Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, Heindenreich PA, Rader DJ, deGoma EM: Statins and cognitive function: a systematic review. Ann Intern Med. 2013, 159: 688-697. 10.7326\/0003-4819-159-10-201311190-00007.","journal-title":"Ann Intern Med"},{"key":"2097_CR49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0022-3565(25)39496-6","volume":"267","author":"A Tsuji","year":"1993","unstructured":"Tsuji A, Saheki A, Tamai I, Terasaki T: Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood\u2013brain barrier. J Pharmacol Exp Ther. 1993, 267: 1085-1090.","journal-title":"J Pharmacol Exp Ther"},{"key":"2097_CR50","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","volume":"289","author":"PD Thompson","year":"2003","unstructured":"Thompson PD, Clarkson P, Karas RH: Statin-associated myopathy. JAMA. 2003, 289: 1681-1690. 10.1001\/jama.289.13.1681.","journal-title":"JAMA"},{"key":"2097_CR51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jacc.2007.02.073","volume":"50","author":"AA Alsheikh-Ali","year":"2007","unstructured":"Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH: Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized trials. J Am Coll Cardiol. 2007, 50: 409-418. 10.1016\/j.jacc.2007.02.073.","journal-title":"J Am Coll Cardiol"},{"key":"2097_CR52","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/ana.10292","volume":"52","author":"M Simons","year":"2002","unstructured":"Simons M, Schw\u00e4rzler F, L\u00fctjohann D, Von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB: Treatment with simvastatin in normocholesterolemic patients with Alzheimer\u2019s disease: a 26-week randomized, placebo-controlled double-blind trial. Ann Neurol. 2002, 52: 346-350. 10.1002\/ana.10292.","journal-title":"Ann Neurol"},{"key":"2097_CR53","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1017\/S0033291798007417","volume":"28","author":"C Oliver","year":"1998","unstructured":"Oliver C, Crayton L, Holland A, Hall S, Bradbury J: A four year prospective study of age-related cognitive change in adults with Down\u2019s syndrome. Psychol Med. 1998, 28: 1365-1377. 10.1017\/S0033291798007417.","journal-title":"Psychol Med"},{"key":"2097_CR54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1348\/014466599162719","volume":"38","author":"J Hon","year":"1999","unstructured":"Hon J, Huppert FA, Holland AJ, Watson P: Neuropsychological assessment of older adults with Down\u2019s syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG). Br J Clin Psychol. 1999, 38: 155-165. 10.1348\/014466599162719.","journal-title":"Br J Clin Psychol"},{"key":"2097_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1046\/j.1365-2788.2000.00305.x","volume":"44","author":"DA Devenny","year":"2000","unstructured":"Devenny DA, Krinsky-McHale SJ, Sersen G, Silverman WP: Sequence of cognitive decline in dementia in adults with Down\u2019s syndrome. J Intellect Disabil Res. 2000, 44: 654-665. 10.1046\/j.1365-2788.2000.00305.x.","journal-title":"J Intellect Disabil Res"},{"key":"2097_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1348\/014466507X230967","volume":"47","author":"SL Ball","year":"2008","unstructured":"Ball SL, Holland AJ, Treppner P, Watson PC, Huppert FA: Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer\u2019s disease in adults with Down syndrome and mild to moderate learning disabilities. Br J Clin Psychol. 2008, 47: 1-29. 10.1348\/014466507X230967.","journal-title":"Br J Clin Psychol"},{"key":"2097_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1352\/0895-8017(2008)113[73:MBRTDS]2.0.CO;2","volume":"113","author":"TK Urv","year":"2008","unstructured":"Urv TK, Zigman WB, Silverman W: Maladaptive behaviors related to dementia status in adults with Down syndrome. Am J Ment Retard. 2008, 113: 73-86. 10.1352\/0895-8017(2008)113[73:MBRTDS]2.0.CO;2.","journal-title":"Am J Ment Retard"},{"key":"2097_CR58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/gps.1545","volume":"21","author":"SL Ball","year":"2006","unstructured":"Ball SL, Holland AJ, Hon J, Huppert FA, Treppner P, Watson PC: Personality and behaviour changes mark the early stages of Alzheimer\u2019s disease in adults with Down\u2019s syndrome: findings from a prospective population-based study. Int J Geriatr Psychiatry. 2006, 21: 661-673. 10.1002\/gps.1545.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2097_CR59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/13668259900033961","volume":"24","author":"AJ Dalton","year":"1999","unstructured":"Dalton AJ, Mehta PD, Fedor BL, Patti PJ: Cognitive changes in memory predate those in praxis in aging persons with Down syndrome. J Intellect Dev Disabil. 1999, 24: 169-187. 10.1080\/13668259900033961.","journal-title":"J Intellect Dev Disabil"},{"key":"2097_CR60","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1352\/2008.113:369-386","volume":"113","author":"SJ Krinsky-McHale","year":"2008","unstructured":"Krinsky-McHale SJ, Devenny DA, Kittler P, Silverman W: Selective attention deficits associated with mild cognitive impairment and early stage Alzheimer\u2019s disease in adults with Down syndrome. Am J Ment Retard. 2008, 113: 369-386. 10.1352\/2008.113:369-386.","journal-title":"Am J Ment Retard"},{"key":"2097_CR61","unstructured":"CANTAB Cambridge Cognition Ltd: Cambridge Neuropsychological Test Automated Battery (CANTAB). Bottisham, UK: Cambridge Cognition"},{"key":"2097_CR62","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2788.2010.01280.x","volume":"54","author":"JD Masson","year":"2010","unstructured":"Masson JD, Dagnan D, Evans J: Adaptation of the Tower of London test of planning and problem solving in people with intellectual disabilities. J Intellect Disabil Res. 2010, 54: 457-467. 10.1111\/j.1365-2788.2010.01280.x.","journal-title":"J Intellect Disabil Res"},{"key":"2097_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-84800-249-4_9","volume-title":"Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities","author":"DA Devenny","year":"2009","unstructured":"Devenny DA, Krinsky-McHale SJ: The Cued Recall Test: detection of memory impairment. Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities. Edited by: Prasher VP. 2009, London: Springer, 143-161."},{"key":"2097_CR64","volume-title":"Rivermead Behavioural Memory Test for Children (RBMT-C)","author":"BA Wilson","year":"1991","unstructured":"Wilson BA, Ivani-Chalian R, Aldrich F: Rivermead Behavioural Memory Test for Children (RBMT-C). 1991, London: Pearson"},{"key":"2097_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4324\/9780203413081_chapter_9","volume-title":"Analyzing Qualitative Data","author":"J Ritchie","year":"1994","unstructured":"Ritchie J, Spencer L: Qualitative data analysis for applied policy research. Analyzing Qualitative Data. Edited by: Bryman A, Burgess RG. 1994, Abingdon, UK: Routledge, 173-194."},{"key":"2097_CR66","volume-title":"AAMR Adaptive Behavior Scale\u2013Residential and Community: Second Edition (Model ABS-RC:2)","author":"K Nihira","year":"1993","unstructured":"Nihira K, Leland H, Lambert N: AAMR Adaptive Behavior Scale\u2013Residential and Community: Second Edition (Model ABS-RC:2). 1993, Austin, TX: PRO-ED"},{"key":"2097_CR67","volume-title":"Health and Deprivation: Inequalities and the North","author":"P Townsend","year":"1988","unstructured":"Townsend P, Phillimore P, Beattie A: Health and Deprivation: Inequalities and the North. 1988, London: Croom Helm"},{"issue":"6","key":"2097_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta5060","volume":"5","author":"RP Riemsma","year":"2001","unstructured":"Riemsma RP, Forbes CA, Glanville JM, Eastwood AJ, Kleijnen J: General health status measures for people with cognitive impairment: learning disability and acquired brain injury. Health Technol Assess. 2001, 5 (6): 1-100.","journal-title":"Health Technol Assess"},{"key":"2097_CR69","first-page":"163","volume-title":"Measuring Mental Health Needs","author":"JK Beecham","year":"1992","unstructured":"Beecham JK, Knapp MRJ: Costing psychiatric interventions. Measuring Mental Health Needs. Edited by: Thornicroft GJ, Brewin CR, Wing JK. 1992, London: Gaskell, 163-183."},{"key":"2097_CR70","first-page":"157","volume-title":"The Economic Evaluation of Mental Health Care","author":"JK Beecham","year":"1995","unstructured":"Beecham JK: Collecting and estimating costs. The Economic Evaluation of Mental Health Care. Edited by: Knapp M. 1995, Arena, UK: Aldershot Books, 157-174."},{"key":"2097_CR71","volume-title":"A User\u2019s Guide to the General Health Questionnaire","author":"DP Goldberg","year":"1988","unstructured":"Goldberg DP, Williams P: A User\u2019s Guide to the General Health Questionnaire. 1988, NFER-Nelson: Windsor, UK"},{"key":"2097_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1745-6215-7-9","volume":"7","author":"AM McDonald","year":"2006","unstructured":"McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, Elbourne DR, Francis D, Garcia J, Roberts I, Snowdon C: What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006, 7: 9-10.1186\/1745-6215-7-9.","journal-title":"Trials"},{"key":"2097_CR73","volume-title":"Cochrane Database Syst Rev","author":"S Treweek","year":"2010","unstructured":"Treweek S, Mitchell E, Pitkethly M, Cook J, Kjeldstr\u00f8m M, Taskila T, Johansen M, Sullivan F, Wilson S, Jackson C, Jones R: Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev. 2010, 1: MR000013"},{"key":"2097_CR74","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2788.2005.00618.x","volume":"49","author":"N Lennox","year":"2005","unstructured":"Lennox N, Taylor M, Rey-Conde T, Bain C, Purdie DM, Boyle F: Beating the barriers: recruitment of people with intellectual disability to participate in research. J Intellect Disabil Res. 2005, 49: 296-305. 10.1111\/j.1365-2788.2005.00618.x.","journal-title":"J Intellect Disabil Res"},{"key":"2097_CR75","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1046\/j.1365-2788.2002.00408.x","volume":"46","author":"PC Oliver","year":"2002","unstructured":"Oliver PC, Piachaud J, Done J, Regan A, Cooray S, Tyrer P: Difficulties in conducting a randomized controlled trial of health service interventions in intellectual disability: implications for evidence-based practice. J Intellect Disabil Res. 2002, 46: 340-345. 10.1046\/j.1365-2788.2002.00408.x.","journal-title":"J Intellect Disabil Res"},{"key":"2097_CR76","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/gps.1306","volume":"20","author":"VP Prasher","year":"2005","unstructured":"Prasher VP, Fung N, Adams C: Rivastigmine in the treatment of dementia in Alzheimer\u2019s disease in adults with Down syndrome. Int J Geriatr Psychiatry. 2005, 20: 496-497. 10.1002\/gps.1306.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2097_CR77","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/gps.587","volume":"17","author":"VP Prasher","year":"2002","unstructured":"Prasher VP, Huxley A, Haque MS, Down Syndrome Ageing study Group: A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer\u2019s disease\u2014pilot study. Int J Geriatr Psychiatry. 2002, 17: 270-278. 10.1002\/gps.587.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2097_CR78","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(11)61676-0","volume":"379","author":"M Hanney","year":"2012","unstructured":"Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C, on behalf of the MEADOWS trial researchers: Memantine for dementia in adults older than 40 years with Down\u2019s syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet. 2012, 379: 528-536. 10.1016\/S0140-6736(11)61676-0.","journal-title":"Lancet"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:16:50Z","timestamp":1746253010000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,3]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2097"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-202","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,3]]},"assertion":[{"value":"7 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"202"}}